Birgitta StÃ…hl
MSc, MBA, Chief Financial Officer
Oncology
Oncopeptides
Sweden
Biography
Birgitta Ståhl was appointed CFO in 2016. Previous positions Birgitta has held include COO and acting CFO at Akinion Pharmaceuticals AB and KDev Oncology AB and Vice President Company Operations at Axelar AB, a Swedish drug development company in the field of oncology. Birgitta holds an MSc Pharm from Uppsala University and an MBA from University of Westminster in London Born: 1971 oldings in Oncopeptides: 3,400 shares (Directly owned or affiliated)
Research Interest
Birgitta holds an MSc Pharm from Uppsala University and an MBA from University of Westminster in London
